Amanda Griggs

Cooley advised Travere Therapeutics, a biopharmaceutical company, on its definitive agreement to sell its bile acid product portfolio to Mirum Pharmaceuticals.

Cooley advised Absolute Software, a data risk management solutions and endpoint security provider, on its acquisition by Crosspoint Capital for approximately $870 million, inclusive of debt.

Cooley advised Redx Pharma, a UK clinical-stage biotechnology company, on its all share merger with Jounce Therapeutics, a US clinical-stage immunotherapy company, in a $425 million and contingent value right transaction.

Cooley advised Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, on its definitive agreement to be acquired by global healthcare company Viatris. Partners Mika Reiner Mayer, Brandon Fenn, Div Gupta and Ian Nussbaum led the Cooley team advising Oyster Point Pharma.

Cooley, which represents more than 600 digital health clients across the healthcare ecosystem, advised One Medical, a human-centered, technology-powered national primary care organization, on a definitive merger agreement under which Amazon will acquire One Medical for $18 per share in an all-cash transaction valued at approximately $3.9 billion, including One Medical’s net debt. Lawyers Steven Tonsfeldt, Matthew Hemington, Anne Lieberman and Gaël Hagan are leading the Cooley team advising One Medical.